SCHEMBL27361620

SCHEMBL27361620

O=S(=O)(CC=Cc1ccc(F)cc1)C1CCNCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
HSD11B1 P28845 1/20 0.37
IKBKB O14920 1/20 0.36
MAOB P27338 1/20 0.36
KMT2A Q03164 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
HTR2A P28223 1/20 0.35
KCNH2 Q12809 1/20 0.35
TNFRSF1A P19438 1/20 0.34
CCR3 P51677 1/20 0.34
GPR183 P32249 1/20 0.33
ALOX5 P09917 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27736334 0.86 USP2 (0.38) MAOBALOX5PTGS1PTGS2MAPT
SCHEMBL27625548 0.86 CYP1A2 (0.36) MAOBKCNH2GPR183LMNA
SCHEMBL27756903 0.82 CYP1A2 (0.41) HSD11B1KMT2AGPR183ALDH1A1LMNA
SCHEMBL27736309 0.80 PYGL (0.42) PTGS2ALDH1A1
SCHEMBL27469722 0.79 SLC6A2 (0.43) HTR2CHTR2BHTR2AKCNH2PTGS1
SCHEMBL28779017 0.76 CYP1A2 (0.42) MAOBKMT2AALDH1A1LMNA
SCHEMBL8487694 0.74 SLC6A2 (0.41) CYP11B1CYP11B2HTR2CHTR2BALDH1A1
SCHEMBL4321271 0.74 CHRM1 (0.42) HSD11B1MAOBKMT2AHTR2CHTR2B
SCHEMBL4321273 0.74 CHRM1 (0.42) HSD11B1MAOBKMT2AHTR2CHTR2B
SCHEMBL27587931 0.72 MAPK1 (0.30) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1282643-C Intermediate for preparing compounds having serotonin-2 receptor antagonistic and alpha-1 blocking action and its preparing method DAIICHI SUNTORY SEIYAKU CO LTD (JP) 2006-11-01 CN disclosed
CN-1193014-C Novol pyrrole sulphamide compound DAICHI SUNTORY PHARMA CO LTD (JP) 2005-03-16 CN disclosed
CN-1528746-A Intermediate for preparing compounds having serotonin-2 receptor antagonistic and alpha-1 blocking action and its preparing method ��һ��������ҩ��ʽ���� 2004-09-15 CN disclosed
CN-1495163-A Novol pyrrole sulphamide compound ��һ��������ҩ��ʽ���� 2004-05-12 CN disclosed
CN-1148372-C Has 5-hydroxytryptamine-2 receptor antagonistic effect and alpha1Azothiazines and pyrrolethiones with blocking actionAzepine compound ��һ��������ҩ��ʽ���� 2004-05-05 CN disclosed
CN-1131870-C Novel pyrrole sulfonamide compounds SUNTORY LTD. (JP) 2003-12-24 CN disclosed
CN-1094126-C Pyrroloazepine compounds SUNTORY LTD (JP) 2002-11-13 CN disclosed
CN-1281854-A Benzothiazine derivative SUNTORY LTD (JP) 2001-01-31 CN disclosed
CN-1058492-C benzothiazine derivatives SUNTORY LTD (JP) 2000-11-15 CN disclosed
CN-1261366-A Azothiazine compounds and pyrrolethiazepine compounds having 5-hydroxytryptamine-2-receptor antagonistic and alpha-1-blocking effects SUNTORY LTD (JP) 2000-07-26 CN disclosed
CN-1260798-A Has 5-hydroxytryptamine-2 receptor antagonistic effect and alpha1Azothiazine and pyrrolethiazepine compounds with blocking action SUNTORY LTD (JP) 2000-07-19 CN disclosed
CN-1219173-A Pyrroloazepine compounds SUNTORY LTD (JP) 1999-06-09 CN disclosed
CN-1119859-A benzothiazine derivatives SUNTORY LTD (JP) 1996-04-03 CN disclosed